Old Web
English
Sign In
Acemap
>
authorDetail
>
S.C.-H. Kuo
S.C.-H. Kuo
Adenocarcinoma
Cancer research
Epidermal growth factor receptor
Endocrinology
Tyrosine-kinase inhibitor
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Co-Expression of Programmed Death-Ligand 1 (PD-L1) Expression in EGFR Mutant Stage IV Lung Adenocarcinoma
2019
P.C. Hsu
C. W. Wang
S.C.-H. Kuo
Cheng-Ta Yang
Show All
Source
Cite
Save
Citations (0)
Supplementary Material for: Overall Response to First-Line Tyrosine Kinase Inhibitor and Second-Line Chemotherapy Is Predictive of Survival Outcome in Epidermal Growth Factor Receptor-Mutated Adenocarcinoma
2017
S.C.-H. Kuo
P.C. Hsu
C-H. Chen
C.T. Yu
C. L. Wang
F.T. Chung
S.-M. Lin
Y. L. Lo
T.C. Chen
C. Y. Liu
C. T. Yang
Show All
Source
Cite
Save
Citations (0)
1